Atypical Hemolytic Uremic Syndrome (aHUS) Recruiting Phase 3 Trials for Iptacopan (DB16200)

Back to Atypical Hemolytic Uremic Syndrome (aHUS)

Also known as: Atypical Hemolytic Uraemic Syndrome / Atypical Hemolytic-Uremic Syndrome / Atypical Hemolytic Uremic Syndrome / Hemolytic-Uremic Syndrome, Atypical / Hemolytic Uremic Syndrome, Atypical / Atypical hemolytic uremic syndrome (disorder) / Atypical haemolytic uraemic syndrome / AHUS

Indication	Status	Phase
DBCOND0061539 (Atypical Hemolytic Uremic Syndrome (aHUS))	Recruiting	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04889430	Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy	Treatment	Iptacopan (DB16200)